Alzheimer's drug shows long-term benefits in behavior and cognition. EU approval of Blarcamesine could boost its market value ...

ORLANDO -- New results from the randomized CAHtalyst trials shed light on the benefits of crinecerfont (Crenessity) for adult and pediatric patients with congenital adrenal hyperplasia (CAH), a rare ...

Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, ...

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

An open-label study of 12 individuals with severe treatment-resistant depression found that their symptoms significantly ...

Data from an open-label trial showed that foralumab treatment eased fatigue and lessened disability for some people with ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

The potential change outlined in a statement says all new vaccines will be required to undergo placebo testing, a procedure in which some people receive the vaccine and others receive an inert ...

They say the authors’ rigorous methodology to compare the magnitude and duration of placebo and nocebo effects in pain perception yields compelling evidence that nocebo responses demonstrate ...

Results from the first patient cohort (N=5) of an open-label proof of concept academic study with low-dose IL-2 and CTLA4-Ig demonstrated a rapid and durable statistically significant increase in ...